Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 23,538 | 38,940 | 27,315 | 12,894 | 3,977 |
| Gross Profit | 23,538 | 38,940 | 27,315 | 12,894 | 3,977 |
| Operating Expenses | 52,842 | 48,907 | 124,591 | 73,069 | 82,057 |
| Operating Income | -29,304 | -9,967 | -97,276 | -60,175 | -78,080 |
| Interest Expense | 0 | 270 | 202 | 735 | 2,427 |
| Other Income | 13,901 | 365 | -37 | 7,454 | 5,111 |
| Pre-tax Income | -15,403 | -9,872 | -97,515 | -53,456 | -75,396 |
| Income Tax | -2,617 | -1,535 | -55 | -18,697 | -18,806 |
| Net Income Continuous | -12,786 | -8,337 | -97,460 | -34,759 | -56,590 |
| Net Income Discontinuous | 2,413 | 6,389 | -654 | 316,447 | 24,847 |
| Net Income | $-10,373 | $-1,948 | $-98,114 | $281,688 | $-31,743 |
| EPS Basic Total Ops | -0.53 | -0.10 | -6.16 | 17.22 | -2.34 |
| EPS Basic Continuous Ops | -0.65 | -0.44 | -6.12 | -2.10 | -4.20 |
| EPS Basic Discontinuous Ops | 0.12 | 0.34 | -0.04 | 19.32 | 1.86 |
| EPS Diluted Total Ops | -0.53 | -0.10 | -6.16 | 17.22 | -2.34 |
| EPS Diluted Continuous Ops | -0.65 | -0.44 | -6.12 | -2.10 | -4.20 |
| EPS Diluted Discontinuous Ops | 0.12 | 0.34 | -0.04 | 19.32 | 1.86 |
| EBITDA(a) | $-28,794 | $-27,184 | $-98,188 | $-59,524 | $-62,161 |